ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,554.89
-0.24%
Gold vs US Dollar
2,333.57
1.35%
Brent Oil
82.425
0.55%
Bitcoin
65,483.20
-1.91%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BioCryst Pharmaceuticals Inc (BCRX) Share Price

BCRX BioCryst Pharmaceuticals Inc

6.105
-0.125 (-2.01%)
Last Updated: 19:44:05
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 BioCryst Pharmaceuticals Inc NASDAQ:BCRX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.125 -2.01 6.105 6.10 6.11 6.16 5.995 6.13 1,416,629 18:44:05   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 331.41M -226.54M -1.0989 -5.56 1.26B
 Type  Size  Price  Time  Units 
 9 1 6.105 18:45:09 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BCRX News
13/06/202421:23EDGAR2Form 8-K - Current report
04/06/202412:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/06/202421:33EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
03/06/202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
02/06/202409:00GLOBEBioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
31/05/202421:25EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
29/05/202421:16EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for BCRX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest BioCryst Pharmaceuticals Inc Articles